packageTirzepatide

tirzepatide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tirzepatide is a blood glucose lowering drug used to treat type 2 diabetes, and also obesity and overweight. It is an approved medicine authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q108324770 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tirzepatide
ATC codes:A10BX16
DrugBank:DB15171
Wikidata:Q108324770
molar mass:4810.52 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown